Kliuchnikova Anna A, Ilgisonis Ekaterina V, Archakov Alexander I, Ponomarenko Elena A, Moskalev Alexey A
Institute of Biomedical Chemistry, Moscow 119121, Russia.
Institute of Longevity, Petrovsky Russian Research Center for Surgery, Moscow 119435, Russia.
Int J Mol Sci. 2024 Nov 25;25(23):12634. doi: 10.3390/ijms252312634.
This article provides a systematic review of research conducted on the proteomic composition of blood as part of a complex biological age estimation. We performed a comprehensive analysis of 17 publicly available datasets and compiled an integral list of proteins. These proteins were sorted based on their detection probability using mass spectrometry in human plasma. We propose this list as a basis for creating a panel of peptides and quantifying the content of selected proteins in the format of a proteomic aging clock. The selected proteins are especially notable for their roles in inflammatory processes and lipid metabolism. Our findings suggest, for the first time, that proteins associated with systemic disorders, including those approved by the FDA for clinical use, could serve as potential markers of aging.
本文对作为复杂生物年龄估计一部分的血液蛋白质组学组成研究进行了系统综述。我们对17个公开可用的数据集进行了全面分析,并编制了一份完整的蛋白质清单。这些蛋白质根据其在人血浆中使用质谱法的检测概率进行分类。我们提出这份清单作为创建一组肽并以蛋白质组学衰老时钟的形式量化所选蛋白质含量的基础。所选蛋白质因其在炎症过程和脂质代谢中的作用而特别显著。我们的研究结果首次表明,与全身性疾病相关的蛋白质,包括那些已获美国食品药品监督管理局批准用于临床的蛋白质,可能作为衰老的潜在标志物。